Icahn To File Lawsuit To Stop Biogen Idec (BIIB) Vote
More News related to BIIB
- Biogen Idec to Present at the 2009 Annual Credit Suisse Healthcare Conference
- Trading Outlook for MannKind Corp. Issued by InvestorSoup.com
- Jefferies & Co Upgrades Biogen Idec (BIIB) to Buy
- Trading Outlook for Metabasis Therapeutics Issued by StockPreacher.com
- Trading Outlook for Incyte Corp. Issued by StockPreacher.com
More News related to Trader Talk
- Moody's Suggests AIG (AIG) Could Repay the U.S.
- S&P Announces Change to US Index: LL for UCBH
- Reports Moody's said AIG (AIG) may be able to repay the U.S.
- Priceline.com (PCLN) Surges 8% After Better-Than-Expected Results
- Buffett's Berkshire To Sell 9.6M Share Stake in Union Pacific (UNP) and 1.9M Share Stake In Norfolk Southern (NSC)
According to reports from CNBC, an Icahn associate is going to Delaware court to stop the shareholder vote at Biogen Idec Inc. (Nasdaq: BIIB). Biogen Idec has taken a recess until 2PM on the vote, which Icahn views as an attempt to change the vote.
An Icahn associate said they believe that if the vote was stopped now and counted they would have two associates nominated to the board.
Shares of BIIB are up 2.9%
Related Categories
Insiders' BlogTrader Talk
Stocks Mentioned
-0.35Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
